ATS is pleased to announce Beta-release of a wide array of targeted toxins for use in eliminating specific cell types. This Beta-Testing Program will make new conjugates available to our customers sooner.
Each of the Beta products has had:
- Saporin activity confirmed,
- Peptide sequences published/confirmed, and/or
- Antibody binding specificity published/confirmed.
Beta Products have not been characterized or reported in scientific literature. This provides researchers with special Beta-pricing and the opportunity to be the first to publish using the material. The researcher who first publishes data will receive a $500 credit for use on ATS products.
Contact ATS to discuss your project.